扩展成本效果分析中纳入财务保护公平性考量的系统综述
Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review
作者：Sarayuth Khuntha、Sitaporn Youngkong、Ukrit Sitthiboot、Montarat Thavorncharoensap、Usa Chaikledkaew、Ammarin Thakkinstian
单位：Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.；Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand; Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. Electronic address: sitaporn.you@mahidol.ac.th.；Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.；Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand; Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.；Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
摘要
ISPOR官方期刊《Value in Health》发表系统综述，评估在扩展成本效果分析(ECEA)中纳入与财务保护相关公平性考量的方法学应用。研究由泰国学者完成，系统梳理了ECEA框架在衡量卫生技术评估中因病致贫风险保护价值的应用现状与方法论进展。
AI 主编 · 推荐理由推荐理由
对开展国际多中心临床试验及全球准入策略的药企有参考价值：ECEA框架正被越来越多新兴市场国家采用，理解财务保护维度有助于优化定价与准入谈判策略，建议HEOR和BD团队关注该方法学进展。